Sector: Pharmaceuticals
Sun Pharmaceutical Industries
Latest: SUNPHARMA received regulatory approval to sell a generic version of semaglutide (the active ingredient in Wegovy/Ozempic), entering the obesity/GLP-1 race.
What it means: Generic approvals for high-demand drugs can open large new revenue streams — competition and pricing matter.
Beginner tip: Evaluate launch timing, patent expiration windows, and expected pricing vs branded drugs.
#WatchOutFor#FundamentalViews#PersonalFinance#MacroViews
1,098 likes·51 comments

















